Near-term applications include combinations with kinase inhibitors (KIs)that achieve enhanced concentration at target sites and synergistic delivery of multiple KIs to the same location HOUSTON, TX / ...
Palm Beach Gardens, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) ("Curative Biotech” or the "Company”), a development-stage biomedical company focused on novel ...
Zacks Investment Research on MSN
Top 3 Genomics Stocks to Consider for Your Portfolio
An updated edition of the Sept. 18, 2025, article. Genomics is a comprehensive study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Given the recent promising breakthroughs ...
Q-linea AB ( ($SE:QLINEA) ) has shared an update. Q-linea AB has submitted a 510(k) application to the FDA for expanded organism and antimicrobial ...
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion ...
More than 20 years of financial and operational leadership in biopharma, including $170M+ in capital raised, global commercialization experience, and a proven track record scaling companies from precl ...
Bioprinting relies on bioinks, which are mixtures of living cells and hydrogels that provide a temporary structural ...
Making biotech more diverse and fair is a big deal, fixing past mistakes and making sure everyone has a chance to be involved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback